Georges Pascal Haber
Showing 1–1 of 1 transcripts.
- Milken Institute47 min
Advancing Precision Oncology: Prevention, Early Detection, & Treatment | Middle East & Africa Summit
Alan Tisch, Georges Pascal Haber, Majed Mohammed, Simranjit Singh, Nicole Sirotin
A comprehensive panel discussion detailed the global shift toward precision oncology and AI-driven drug discovery, highlighting how biomarker-specific treatments and metabolic interventions are projecting a transition where cancer becomes a manageable chronic condition by 2050. The event underscored strategic initiatives in the UAE, including the Emirati Genome Project and GLP-1 repurposing, which aim to address regional screening disparities and reduce mortality through early detection and preventive care models. Experts further emphasized the integration of robotic surgery advancements and mRNA technologies alongside robust patient advocacy to bridge the gap between innovative clinical protocols and accessible public health infrastructure.